Role of extracellular matrix in the action of basic fibroblast growth factor: Matrix as a source of growth factor for long‐term stimulation of plasminogen activator production and DNA synthesis
- 1 July 1989
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 140 (1) , 75-81
- https://doi.org/10.1002/jcp.1041400110
Abstract
When bovine capillary endothelial (BCE) cells were treated with 10 ng/ml of basic fibroblast growth factor (bFGF) for 10 or 30 minutes at 37°C, washed extensively with phosphate-buffered saline (PBS) and incubated in bFGF-free medium, plasminogen activator (PA) production was stimulated to the same extent as in cells exposed continuously to bFGF. Three methods of removing bFGF from heparin-like binding sites in the extracellular matrix, but not from bFGF receptors, abolished this long-term effect of a brief exposure to bFGF. First, BCE cells exposed to bFGF for 30 minutes were washed with 2M NaCI and incubated in bFGF-free medium. Second, BCE cells were incubated with bFGF for 10 minutes in the presence of heparin, and cells were washed with PBS and incubated in bFGF-free medium. Third, BCE cell cultures were treated with heparinase and exposed to bFGF. Each of these treatments abolished the long-term (24-48 hours) stimulation of PA production normally observed after brief exposure to bFGF. In each of these experiments, incubation of cells in bFGF-containing medium after the treatments resulted in normal stimulation of PA production, demonstrating that the treatments did not harm the cells. Stimulation of DNA synthesis was observed when cells were exposed to bFGF for 2 hours at 4°C, incubated in bFGF-free medium for 24 hours at 37°C, and assayed for 3H-thymidine incorporation. However, no stimulation was observed if the 2 hours incubation at 4°C was carried out in the presence of heparin. Thus, long-term stimulation of PA activity and DNA synthesis after a brief exposure to bFGF seems to be a consequence of bFGF binding to the extracellular matrix. The extracellular matrixmay act as a physiologic buffer, binding bFGF when concentrations are high and releasing it later for interaction with its receptor. This interaction with matrix may be required for the in vivo action of bFGF.This publication has 31 references indexed in Scilit:
- Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active formJournal of Cellular Physiology, 1989
- Sulfated glycosaminoglycans modify growth factor‐induced neurite outgrowth in PC12 cellsJournal of Cellular Physiology, 1988
- Specific fixation of bovine brain and retinal acidic and basic fibroblast growth factors to mouse embryonic eye basement membranesExperimental Cell Research, 1987
- A form of human basic fibroblast growth factor with an extended amino terminusBiochemical and Biophysical Research Communications, 1987
- Cloning and expression of cDNA encoding human basic fibroblast growth factorFEBS Letters, 1987
- Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells invitro: Implications for a role of heparinase-like enzymes in the neovascular responseBiochemical and Biophysical Research Communications, 1987
- Identification of the fibroblast growth factor receptor of Swiss 3T3 cells and mouse skeletal muscle myoblastsBiochemistry, 1986
- Effect of heparin on the stimulation of non-vascular cells by human acidic and basic FGFBiochemical and Biophysical Research Communications, 1986
- Effect of fibroblast growth factor and lipoproteins on the proliferation of endothelial cells derived from bovine adrenal cortex, brain cortex, and corpus luteum capillariesJournal of Cellular Physiology, 1986
- Human brain-derived acidic and basic fibroblast growth factors: Amino terminal sequences and specific mitogenic activitiesBiochemical and Biophysical Research Communications, 1986